EP3454818A1 - Adapter - Google Patents
AdapterInfo
- Publication number
- EP3454818A1 EP3454818A1 EP17721142.2A EP17721142A EP3454818A1 EP 3454818 A1 EP3454818 A1 EP 3454818A1 EP 17721142 A EP17721142 A EP 17721142A EP 3454818 A1 EP3454818 A1 EP 3454818A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- insert
- wall
- outer body
- adapter
- adapter according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims abstract description 3
- 230000002093 peripheral effect Effects 0.000 claims description 34
- 238000003466 welding Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 239000007788 liquid Substances 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2079—Filtering means
- A61J1/2086—Filtering means for fluid filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3205—Separate rigid or semi-rigid containers joined to each other at their external surfaces
- B65D81/3211—Separate rigid or semi-rigid containers joined to each other at their external surfaces coaxially and provided with means facilitating admixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
Definitions
- the invention relates to an adapter for passing a substance from a first container into a second container, such as syringe body, comprising a suitable for receiving the first container peripheral wall along and extending coaxially at least partially surrounded by this, a cannula body, and one with the Cannula body associated hollow cylindrical portion which is connectable to the second container, wherein the cannula body extend with its longitudinal axis perpendicular to one side of a transverse wall extending transversely to the peripheral wall and the hollow cylindrical portion with its longitudinal axis perpendicular to the other side of the wall.
- US-B-6,558,365 discloses a device for mixing existing in containers fluids, which consists of two adapters, which are connected to each other in the manner of a screw connection via Luer-Lock-cone. It is also possible to connect the female Luer-lock cone having adapter with a syringe body.
- DE 10 2012 113 002 AI discloses a transfer device for removal or transfer of a fluid, which consists of a first and one of these in Longitudinal axis direction displaceable second part consists. In order to enable a displacement of the parts to each other, one of the parts must enclose the opening area of a container.
- Object of the present invention is to develop an adapter of the type mentioned so that it is easy to handle, provides sufficient stability and in particular is excluded that by external detection of the adapter recorded by this container - also called Vial - unintentionally position changed becomes. Also, if possible, be given the opportunity to make simple adjustments to containers of different sizes.
- the adapter has a cup-shaped outer body withargin and the wall which extends transversely to the longitudinal axis of the outer body, and that the cup-shaped outer body has an insert with the container receiving peripheral wall.
- the invention is characterized in that the adapter has a cup-shaped outer body witharginswandung and the wall which extends transversely to the longitudinal axis of the outer body, and that the cup-shaped outer body has an insert with the container receiving peripheral wall, wherein from the bottom wall of the insert the cannula body and emanate from the wall of the cup-shaped outer body of the hollow cylindrical portion.
- Pot-shaped means that the outer body has basically a hollow cylinder geometry on the circumference, even if the outer body can also have on the outside a deviating geometry.
- the term pot-shaped outer body also includes such a whose outer geometry z. B. the a polygonal column like cuboid shape.
- cup-shaped is to be understood as a synonym.
- a cup-shaped outer body is intended in particular to convey that the outer body has a cylinder geometry on the inside.
- the outer body should furthermore be circumferentially slit-free, that is, in departure from the prior art from the end edge, no slots extending in the longitudinal axis direction of the adapter are present in order to achieve flexibility.
- the outer body is referred to as peripherally closed.
- the outer body is bounded on one of its end faces by a wall, which is to be referred to as the end wall. This should be perpendicular to the longitudinal axis of the outer body.
- a separate receptacle forming an insert is provided for the container (vial), which is located within the pot-shaped or hollow body-shaped outer body, so to speak, being made of a relatively stiff material, in particular plastic material which maintains its geometry in capturing the outer body.
- the adapter has sections separated on the circumference by slots in order to receive a vial, so that the adapter parts are peripherally flexible.
- the outer body and the insert form a unit. Outer body and insert are not mutually displaceable in the longitudinal direction. For this purpose, the outer body and the insert are connected to each other, in particular cohesively.
- the unit formed in this way is pushed onto a vial or the vial is introduced into the unit. A relative displacement in the longitudinal axis direction between the outer body and insert does not take place.
- the pot-shaped or hollow-body-shaped outer body of the adapter forms a housing which, at least in sections, can have a cylinder geometry on the outside.
- the insertable in the outer pot or hollow body-shaped body and with this particular cohesive use also results in the advantage that between the bottom wall of the insert and the bottom or Querbegrenzungswandung forming wall of pot or Hollow body-shaped outer body easily a filter element can be positioned and fixed.
- This may be previously connected to the outer surface of the bottom wall of the insert as welded, then to connect the insert with the wall of the pot or hollow body-shaped outer body in particular by means of ultrasonic welding material fit such that the bottom wall is connected to the liquid-tight wall.
- This ensures that when connected to the second container, in particular syringe body, adapter flowing through the particular designed as a Luer cone hollow cylindrical portion of liquid flowing exclusively through the filter from a vial into the second container.
- a filter it should be designed as a surface filter.
- Filter fabric is placed between two surfaces.
- the entire surface along which the filter fabric extends be provided with regular centric recesses.
- the supply as well as discharge of the liquid is preferably carried out via four symmetrically arranged centrally extending channels, which leads the liquid to a central recess.
- the projections in the surface serve as a support of the tissue and thus as a bearing surface.
- the female Luer cone makes it easy to remove the prepared medication without the need for a metal cannula. Thus, a needle-free removal is given.
- the container (vial) is provided in particular that the peripheral wall of the insert, in particular concentrically surrounded by the outer peripheral wall of the outer body as housing radially to the interior of the insert extending projections for holding the container, wherein the peripheral wall spaced at least in the region of the projections Inside the deliberatelymayswandung runs.
- the peripheral wall is preferably completely covered by the outer peripheral wall, but at least in the region of the projections.
- the projections are used in particular to cover a bead-like edge of the vial. So that the elastically bendable projections, which originate from wall sections of the circumferential wall, can be adjusted to the required extent, the peripheral wall is spaced at least in the region of the projections from the outer peripheral wall. In particular, it is provided that the circumferential wall runs at a distance from the outer circumferential wall as a whole.
- the z. B designed as a Luer cone hollow cylindrical portion of the wall of the housing.
- preferably designed as a plastic spike also extends as a cannula body to be designated hollow needle body oppositely extending to the hollow cylindrical portion of the bottom wall in the interior of the recorded by the housing insert.
- the outside bottom surface of the insert, along which the filter extends, should be structured, so that a flat abutment of the filter element is avoided.
- the insert comprises a cylindrical first section extending on the bottom side and a second section of larger outside diameter merging over a step and forming the circumferential wall.
- the insert is made in particular for the insert to be connected to the hollow-body-shaped outer body so as to be circumferentially liquid-tight, wherein in particular a cohesive connection exists, which can be produced by means of ultrasonic welding.
- cup-shaped outer body and the existing in this use are designed in particular as injection molded parts.
- FIG. 2 shows the adapter according to FIG. 1 in a perspective view
- FIG. 3 shows the adapter according to FIGS. 1 and 2 partly with an interior view
- FIG. 5 shows the adapter of FIG. 1 - 4 in longitudinal section
- FIG. 6 the adapter of FIG. 1 - 5 in side view
- FIG. 7 the adapter of FIG. 1 - 6 with vial and syringe body.
- an adapter 14 is shown in principle.
- the adapter 14 serves to receive a container or vial, which is also referred to as vial 10. Furthermore, the adapter 14 is to be connected to a second container, in particular syringe body 12, in order to withdraw a medicinal substance from the vial 10 received by the adapter 14.
- the adapter 14 has a cup-shaped outer body 18 to be designated as a housing, which consists of an outer peripheral wall 32 having a hollow cylinder geometry and a wall 24 bordering the latter on the front side.
- the outer peripheral wall 32 is circumferentially closed and consists in particular of a dimensionally stable plastic.
- a dimensional stability is such that upon detection of the adapter 14 this is basically not deformable.
- the invention is not abandoned when the outer geometry of the peripheral wall 32 deviates from a cylinder geometry.
- the inner geometry of the outer body 18 should have a cylindrical shape.
- the wall 24 which will also be referred to below as the end wall, merges via a step 24 into a radially projecting and flange-forming edge 25 which protrudes from the circumferential wall 32.
- the edge 25 is flattened on diametrically opposite sides, as is apparent from the drawings. This is a problem-free detection of the housing, so the outer body 18 possible. At the same time offers a roll protection.
- a hollow cylindrical portion 26 which may be formed as a female Luer-lock cone. This serves to connect to the second container as the syringe body 12th
- an insert 46 is introduced, which is in particular cohesively connected to the end wall 24 and preferably circumferentially connected thereto.
- the insert 46 has a coaxial with the outer peripheral wall 32 extending peripheral wall 47, which consequently extends concentrically around the longitudinal axis of the outer body 18 and thus of the adapter 14.
- the longitudinal axis is illustrated by the dot-dash line 27.
- the insert 46 serves as a receptacle or holder for the vial 10 to be fixed. For this project from the peripheral wall 47 of the insert 46 in the interior of the insert 46 extending projections 48, 50, 52 into it, which is a hook-shaped geometry, ie in section Triangle geometry may have, after proper insertion of the vial 10 to cover the bead-like edge and thus ensure a fixing.
- the insert 46 i. its peripheral wall 47 at least in the region of the projections 48, 50, 52, but preferably fully, spaced to the inside of the outer peripheral wall 32 of the outer body 18.
- Further Aussparrungen 49, 51, 53 are provided, which between the projections 48, 50, 52 and the extend along the end wall 24 extending bottom wall 54 of the insert 46.
- the bottom wall 54 runs at the outer body 18 connected to the insert 46 along the inside of the end wall 24, wherein between the inside of the end wall 24 and the outside of the intermediate wall 54, a planar filter 56th can be provided. This is shown in FIG. 5.
- the filter 56 may have previously been fixed on the outside of the bottom wall 54 of the insert 46, before the insert 46 is inserted into the outer body 18 and connected thereto.
- the bottom wall 54 and the end wall 24 extend perpendicular to the longitudinal axis 27.
- the bottom wall 54 has a protruding circumferential and lying on a circular ridge 58 on the outside thereof, which is insertable into a corresponding Aussparrung 60 in the end wall 24, thus allowing a centering.
- Other centering measures are also possible and are covered by the invention.
- Corresponding centering also includes punctually arranged centering.
- the insert 46 in the region of the inside of the step 124 can likewise have a step-shaped geometry, which additionally ensures a desired coaxial alignment of the insert 46 with the outer body 18.
- the bottom wall 54 merges via a step 80 in the peripheral wall 47, so that the insert 46 basically composed of two cylindrical sections, namely the limited of the bottom wall 54 and the outer hollow cylindrical portion of larger cross section, from which the projections 48, 50, 52 protrude radially inwards.
- the insert 46 should be materially connected to the end wall 24 in particular by means of ultrasonic welding, whereby a liquid-tightness between the insert 46 and the end wall 24 is ensured.
- From the bottom wall 54 extends opposite to the female Luer lock cone 26 extending a hollow piercing mandrel forming plastic spike 64 with a tip 66 which passes through when inserting the vial 10 in the insert 46 whose closure so that a compound on the female Luer-Lock cone 26 can be made to a syringe body, not shown, and connected to the Luer-lock cone 26.
- the hollow puncture mandrel may also be referred to as a hollow needle body or cannula body or with other paraphrasing and is preferably made of plastic.
- the component "cannula” is therefore not necessarily to express that is used as a material metal.
- the bearing surface that is to say the outer side of the bottom wall 54 of the insert 46, along which the filter 56 extends, is structured so that the liquid to be drawn off is distributed and then conveyed via the female luer lock. Cone 26 can reach the syringe body, not shown.
- the housing that is to say the outer body 18, consists in particular of a polyolefin, in particular polypropylene.
- the wall thickness of the outer peripheral wall 32 may be in the range between 1.2 mm and 1.6 mm.
- the outer surface of the outer circumferential wall 32 has knob-like projections and spherical segment-like depressions, thereby facilitating the detection of the outer body 18.
- the corresponding elements are identified by the reference numerals 132, 134 by way of example.
- Fig. 7 the adapter 14 is shown, which is connected to the vial 10 on the one hand and the syringe body 12 via the female Luer-lock cone 26 on the other.
- the female Luer lock cone 26 is known to cooperate with a male Luer lock cone of the syringe body 12.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016110569.4A DE102016110569B3 (de) | 2016-06-08 | 2016-06-08 | Adapter |
PCT/EP2017/060503 WO2017211505A1 (de) | 2016-06-08 | 2017-05-03 | Adapter |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3454818A1 true EP3454818A1 (de) | 2019-03-20 |
EP3454818B1 EP3454818B1 (de) | 2020-11-18 |
Family
ID=58668898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17721142.2A Active EP3454818B1 (de) | 2016-06-08 | 2017-05-03 | Adapter |
Country Status (14)
Country | Link |
---|---|
US (1) | US10888498B2 (de) |
EP (1) | EP3454818B1 (de) |
JP (1) | JP6957612B2 (de) |
KR (1) | KR102360299B1 (de) |
CN (1) | CN109562022B (de) |
AU (1) | AU2017278373B2 (de) |
BR (1) | BR112018075412B1 (de) |
CA (1) | CA3026160C (de) |
DE (1) | DE102016110569B3 (de) |
EA (1) | EA036730B1 (de) |
ES (1) | ES2853208T3 (de) |
IL (1) | IL263438B (de) |
MX (1) | MX2018015195A (de) |
WO (1) | WO2017211505A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202020101900U1 (de) * | 2020-04-07 | 2021-07-13 | Neoperl Gmbh | Sanitäres Einsetzteil |
WO2023028009A1 (en) * | 2021-08-25 | 2023-03-02 | Scatter, LLC | Connectors and methods for contactless transfer of fluid between containers |
DE102021125666A1 (de) | 2021-10-04 | 2023-04-06 | Sfm Medical Devices Gmbh | Transfervorrichtung |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5060704A (en) | 1990-05-25 | 1991-10-29 | David Bull Laboratories Pty. Ltd. | Suction transfer assembly |
JPH05317383A (ja) * | 1992-05-19 | 1993-12-03 | Nissho Corp | 薬剤容器との連通手段を備えた溶解液容器 |
FR2738550B1 (fr) * | 1995-09-11 | 1997-11-07 | Biodome | Dispositif d'obturation d'un recipient lui-meme ferme, ensemble pour dispenser un produit comprenant un tel recipient et un tel dispositif d'obturation |
US5924584A (en) * | 1997-02-28 | 1999-07-20 | Abbott Laboratories | Container closure with a frangible seal and a connector for a fluid transfer device |
US6558365B2 (en) * | 2001-01-03 | 2003-05-06 | Medimop Medical Projects, Ltd. | Fluid transfer device |
WO2003000170A1 (fr) | 2001-06-22 | 2003-01-03 | Otsuka Pharmaceutical Factory, Inc. | Bouche de recipient destinee a au traitement de melangeage et de remplissage et recipient d'infusion utilisant ladite bouche |
US6948522B2 (en) * | 2003-06-06 | 2005-09-27 | Baxter International Inc. | Reconstitution device and method of use |
JP3883527B2 (ja) * | 2003-07-17 | 2007-02-21 | ニプロ株式会社 | トランスファーニードル |
EP2540276B1 (de) * | 2006-05-25 | 2016-03-16 | Bayer Healthcare LLC | Verfahren zur Herstellung einer Rekonstitutionsvorrichtung |
CA2678198A1 (en) * | 2009-09-08 | 2011-03-08 | Duoject Medical Systems Inc. | Ez-linking device for fluid transfer |
WO2011104711A1 (en) * | 2010-02-24 | 2011-09-01 | Medimop Medical Projects Ltd | Fluid transfer assembly with venting arrangement |
JP5502579B2 (ja) | 2010-04-21 | 2014-05-28 | テルモ株式会社 | 医療用具接続具および薬剤投与具 |
US8857470B2 (en) * | 2011-01-25 | 2014-10-14 | Fresenius Kabi Deutschland Gmbh | Connection device for connecting a first reservoir with a second reservoir |
AU2012225163B2 (en) * | 2011-03-04 | 2016-05-12 | Duoject Medical Systems Inc. | Easy linking transfer system |
SG11201404436XA (en) * | 2012-02-02 | 2014-08-28 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling with a medical container |
EP2856999B1 (de) * | 2012-05-31 | 2017-06-21 | Kinki University | Belichtungsverhindernde kappe |
EP2872100B1 (de) | 2012-09-13 | 2017-03-29 | Medimop Medical Projects Ltd | Teleskopischer buchsenadapter für arzneimittelphiole |
DE102012113002B4 (de) | 2012-10-01 | 2014-04-30 | Medac Gesellschaft für klinische Spezialpräparate mbH | Transfervorrichtung zur Entnahme oder Übergabe eines Fluids |
US10022301B2 (en) * | 2013-03-15 | 2018-07-17 | Becton Dickinson and Company Ltd. | Connection system for medical device components |
CN105228676B (zh) | 2013-05-10 | 2018-01-05 | 麦迪麦珀医疗工程有限公司 | 包括具有内联干燥药物组件的小瓶转接器的医疗装置 |
US9371925B2 (en) * | 2013-07-30 | 2016-06-21 | Tescom Corporation | Fluid regulators having corrugated diaphragms |
WO2015021236A2 (en) * | 2013-08-07 | 2015-02-12 | Unitract Syringe Pty Ltd | Retainer for retractable needle assemblies and syringes |
DK3107618T3 (da) * | 2014-02-20 | 2020-01-27 | Repro Med Systems Inc | Konnektor med filter |
ES2925687T3 (es) * | 2014-04-21 | 2022-10-19 | Becton Dickinson & Co Ltd | Adaptador de jeringa con mecanismo de retroalimentación de desconexión |
JP6340898B2 (ja) | 2014-05-02 | 2018-06-13 | 株式会社ジェイ・エム・エス | 医薬品容器用コネクタ |
DE102015107312A1 (de) * | 2014-12-30 | 2016-06-30 | Sfm Medical Devices Gmbh | Misch- und oder Transfervorrichtung |
-
2016
- 2016-06-08 DE DE102016110569.4A patent/DE102016110569B3/de active Active
-
2017
- 2017-05-03 CN CN201780035656.9A patent/CN109562022B/zh active Active
- 2017-05-03 US US16/306,121 patent/US10888498B2/en active Active
- 2017-05-03 WO PCT/EP2017/060503 patent/WO2017211505A1/de unknown
- 2017-05-03 AU AU2017278373A patent/AU2017278373B2/en active Active
- 2017-05-03 JP JP2019517143A patent/JP6957612B2/ja active Active
- 2017-05-03 MX MX2018015195A patent/MX2018015195A/es unknown
- 2017-05-03 KR KR1020197000265A patent/KR102360299B1/ko active IP Right Grant
- 2017-05-03 EP EP17721142.2A patent/EP3454818B1/de active Active
- 2017-05-03 BR BR112018075412-9A patent/BR112018075412B1/pt active IP Right Grant
- 2017-05-03 EA EA201892799A patent/EA036730B1/ru unknown
- 2017-05-03 CA CA3026160A patent/CA3026160C/en active Active
- 2017-05-03 ES ES17721142T patent/ES2853208T3/es active Active
-
2018
- 2018-12-03 IL IL263438A patent/IL263438B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL263438A (en) | 2019-01-31 |
CN109562022A (zh) | 2019-04-02 |
EA036730B1 (ru) | 2020-12-14 |
MX2018015195A (es) | 2019-04-22 |
AU2017278373A1 (en) | 2019-01-03 |
CA3026160C (en) | 2021-04-13 |
DE102016110569B3 (de) | 2017-10-26 |
KR20190016076A (ko) | 2019-02-15 |
US10888498B2 (en) | 2021-01-12 |
CN109562022B (zh) | 2022-02-11 |
JP6957612B2 (ja) | 2021-11-02 |
KR102360299B1 (ko) | 2022-02-10 |
BR112018075412A2 (pt) | 2019-03-19 |
WO2017211505A1 (de) | 2017-12-14 |
ES2853208T3 (es) | 2021-09-15 |
EP3454818B1 (de) | 2020-11-18 |
CA3026160A1 (en) | 2017-12-14 |
EA201892799A1 (ru) | 2019-05-31 |
JP2019517376A (ja) | 2019-06-24 |
IL263438B (en) | 2022-04-01 |
BR112018075412B1 (pt) | 2024-01-30 |
AU2017278373B2 (en) | 2019-10-10 |
US20190142696A1 (en) | 2019-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2252249B1 (de) | Mischvorrichtung | |
EP3240520B1 (de) | Misch- und/oder transfervorrichtung | |
EP0915737B1 (de) | Aufnahmeeinrichtung | |
EP2667838B1 (de) | Verbindungsvorrichtung zum verbinden eines ersten reservoirs mit einem zweiten reservoir | |
EP2528574B1 (de) | Konnektor für medizinischen wirkstoff enthaltende behälter | |
EP3044104B1 (de) | Ampulle für eine medizinische flüssigkeit und verfahren zum herstellen einer ampulle | |
DE102008048988A1 (de) | Vorrichtung zum Anschluss einer Spritze an ein Behältnis oder eine Schlauchleitung | |
EP1713430A1 (de) | Medizinisches transfergerät | |
EP3054850B1 (de) | Abnahmebaugruppe, insbesondere für blutproben | |
WO2012116791A1 (de) | Verschluss und verfahren zur herstellung eines verschlusses | |
EP2903583A1 (de) | Transfervorrichtung zur entnahme oder übergabe eines fluids | |
EP3454818A1 (de) | Adapter | |
CH627642A5 (de) | Behaelter mit verschluss. | |
EP3297596A1 (de) | Anschlussbaugruppe zum leiten einer medizinischen flüssigkeit | |
EP1963193B1 (de) | Universelle verschlussvorrichtung | |
DE3628337C2 (de) | ||
DE102006040670A1 (de) | Vorrichtung zur Entnahme von Flüssigkeiten | |
EP3174812A1 (de) | Behälter mit kopfstück, der mit einem medium befüllbar oder befüllt ist | |
WO2018060333A1 (de) | Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit | |
AT517083B1 (de) | Abnahmebaugruppe, insbesondere für eine geringere Aufnahmemenge | |
EP2712603B1 (de) | Medizinischer Behälter | |
EP1721595B2 (de) | Behälter für die Bereitstellung medizinischer Flüssigkeiten | |
EP3290017B1 (de) | Blutplasma-flasche | |
AT516438B1 (de) | Handhabungsvorrichtung sowie Verfahren zu deren Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181212 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20191004 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200330 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20200827 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502017008263 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1334951 Country of ref document: AT Kind code of ref document: T Effective date: 20201215 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: LUCHS AND PARTNER AG PATENTANWAELTE, CH |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20201118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210218 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210318 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210219 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210218 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210318 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502017008263 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2853208 Country of ref document: ES Kind code of ref document: T3 Effective date: 20210915 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20210819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210503 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1334951 Country of ref document: AT Kind code of ref document: T Effective date: 20220503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170503 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240521 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240523 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240602 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240627 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240528 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201118 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240524 Year of fee payment: 8 |